Aperio Group, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,000
-86.7%
994
-91.1%
0.00%
Q3 2017$15,000
-63.4%
11,161
-57.7%
0.00%
Q2 2017$41,000
-51.8%
26,3960.0%0.00%
-100.0%
Q1 2017$85,000
+150.0%
26,396
+5.9%
0.00%
Q4 2016$34,000
+88.9%
24,920
+115.0%
0.00%
Q3 2016$18,000
-69.5%
11,591
+3.5%
0.00%
-100.0%
Q1 2016$59,000
-57.2%
11,194
-11.4%
0.00%0.0%
Q2 2015$138,00012,6350.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders